Source: Annual Congress 2001 - Novel approaches to treatment of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. V. Evsyukova, G. B. Fiedosiejev (Saint-Petersburg, Russia). Aspirin-induced asthma (AIA) as the manifestation of low melatonin production and platelet's pathology. Eur Respir J 2001; 16: Suppl. 31, 2907

Member's Comments

No comment yet.

Related content which might interest you: Aspirin-induced asthma as the pathology of the platelet‘s melatonin production Source: Eur Respir J 2006; 28: Suppl. 50, 236s Year: 2006 The pathology of the platelet‘s melatonin production in aspirin-induced asthma Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007 Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002 Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017 Year: 2017 Increased bronchial hyperreactivity (BHR) in sarcoidosis patients maybe a risk factor for progression of the disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003 Are inflammatory phenotypes in children with severe asthma stable? Source: Annual Congress 2007 - Pathophysiology of childhood asthma: new insights Year: 2007 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Severe asthma: from inflammatory phenotype to treatment Source: International Congress 2017 – Chinese Programme 2017 Year: 2017 Inflammatory phenotype of children with severe asthma Source: Annual Congress 2007 - Pathophysiology of childhood asthma: new insights Year: 2007 Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Omalizumab decreases IgE production in patients with severe allergic asthma Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Respiratory syncytial-virus induced cytokine production from leukocytes is impaired in severe asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 The effects of IL12B promoter polymorphism on co-existence of allergic rhinitis or familial asthma history, serum total IgE and eosinophil level in asthma patients Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021 Conclusion: clinical phenotypes of asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005 Comparison of two published definitions of sputum neutrophilia show clinical measures of disease are more severe in neutrophilic asthma (NA) than non-neutrophilic asthma (NNA) using >40% sputum neutrophils as the definition of disease. Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020